You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

 

Online download statistics by month:

Online download statistics by month: May 2020 to September 2024

AbstractFullPdf
May 2020142142107
Jun 2020197197117
Jul 2020818118
Aug 2020848233
Sep 2020868615
Oct 202010210238
Nov 2020868519
Dec 2020939335
Jan 202114914960
Feb 202112812830
Mar 202113013038
Apr 202113013040
May 2021969629
Jun 202110210228
Jul 202111511534
Aug 2021737335
Sep 202110510532
Oct 2021787845
Nov 202111311233
Dec 2021898926
Jan 202212013527
Feb 2022899927
Mar 2022879422
Apr 202210411636
May 202214915731
Jun 20229910328
Jul 20229510834
Aug 2022959719
Sep 2022747717
Oct 202211511832
Nov 202224625745
Dec 2022899116
Jan 2023757520
Feb 202311511618
Mar 2023879219
Apr 2023919435
May 202311311446
Jun 2023747513
Jul 2023889136
Aug 2023888819
Sep 2023676716
Oct 2023747725
Nov 2023868726
Dec 2023707432
Jan 2024373822
Feb 2024515218
Mar 2024717253
Apr 202414314424
May 2024455028
Jun 2024515126
Jul 2024777924
Aug 2024616224
Sep 2024515220
Total515652771690